Finance
Drug discovery company announced private placement
Published in Biotech Business Week, January 24th, 2005
The first tranche that has closed amounted to $24.3 million and the second tranche will be $18.3 million upon the completion of certain ongoing development milestones. New investors HBM BioVentures (Cayman) Ltd. and HBM BioCapital LP led the round.
Other new investors include Advent International, InterWest Partners, Genavent Partners (Sanofi-Aventis) and Red Abbey Venture Partners. Investors returning for this fourth financing round include Alta Partners, Forward Ventures, GIMV, Novartis Bioventure Fund, Pacific...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Breast Cancer
Breast cancer may be uniquely sensitive to inhibitors of PI3K pathway - Collaborations
New anti-angiogenesis program added to collaborative agreement - Coronary Heart Disease
Report: Catheters set to play an expanding role in interventional cardiology - Drug Development
Molecular diversity management schemes for compound screening outlined - Surgical Technology
Report looks at European market for bone morphogenic proteins in spine fusion - Acute Myeloid Leukemia
57.9% of elderly acute myeloid leukemia study patients respond to chemotherapy - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
